You are viewing a free limited preview of Amedica Corporation
Get Full Access To This Report 
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
Amedica Corporation is a privately-held, venture capital backed orthopedic implant and instrument company. Amedica developed the technology to create medical grade silicon nitride ceramic, a material that, compared to others on the market, promises implants with excellent mechanical properties, higher wear resistance, and greatly improved compatibility with MRI, fluoroscopy and CT imaging systems. Founded in 1996, Amedica is headquartered in Salt Lake City, Utah.
| Company Tags: | VC Backed |
| Year Founded: | 1996 |
| Formerly Named: | Amedica Corp. |
| Fiscal Year End: | 12/31 |
| City: | Salt Lake City |
| State/Province: | Utah |
| Country: | United States |
| Phone: | View |
| Website: | www.amedicacorp.com |
| Brands: | Amedica Valeo |
| Healthcare > Medical Devices & Equipment > Other Medical Devices & Equipment |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Export All Amedica Corporation Financials To Excel
$99 Single Company AccessInstant Full Site-Wide Access| Income Statement | 2006 | 2005 |
| Revenue from Grants | View | $69,207 |
| Selling and Marketing Expenses | View | $416,847 |
| General and Administrative Expenses | View | $576,295 |
| Research and Development Expense (Excluding In - Process) | View | $2,966,991 |
| Total Operating Expenses excluding costs | View | $3,960,133 |
| Operating Income/(Loss) | View | ($3,890,926) |
| Interest Expense | View | $0 |
| Interest Income | View | $248,838 |
| Other Non-operating Gains/(Losses) | View | ($577,000) |
| Non-operating Income/(Expense) | View | ($328,162) |
| Net Income (Loss) | View | ($4,219,088) |
| Balance Sheet | 2006 | 2005 |
| Cash and Cash Equivalents | View | $1,252,570 |
| Current Marketable Securities | View | $4,927,251 |
| Accrued Interest | View | $52,240 |
| Prepaid Expenses | View | $18,550 |
| Current Assets | View | $6,250,611 |
| Net Property, Plant and Equipment | View | $1,370,278 |
| Deferred Financing Costs | View | $115,297 |
| Restricted Cash | View | $100,000 |
| Deposits Assets Noncurrent | View | $151,508 |
| Assets | View | $7,987,694 |
| Accounts Payable | View | $207,216 |
| Accrued Expenses | View | $175,623 |
| Current Deferred/(Unearned) Revenue | View | $0 |
| Current Other Deferred Liability Charges | View | $12,910 |
| Current Portion of Long-Term Debt | View | $0 |
| Current Liabilities | View | $395,749 |
| Long-Term Debt | View | $0 |
| Derivative Liabilities - Long-Term | View | $1,404,000 |
| Deferred/(Unearned) Revenue - Long-Term | View | $98,933 |
| Other Deferred Long Term Liability Charges | View | $2,506 |
| Convertible Preferred Stock Obligations | View | $12,153,095 |
| Common Stock - Value (Excluding Additional Paid in Capital) | View | $22,658 |
| Additional Paid in Capital | View | $379,996 |
| Retained Earnings | View | ($6,448,038) |
| Other Accumulated Comprehensive Income, Net of Tax Effect | View | ($21,205) |
| Stockholders' Equity | View | ($6,066,589) |
| Liabilities and Stockholders' Equity | View | $7,987,694 |
| Cash Flow Statement | 2006 | 2005 |
| Operating Activities Beginning Net Income | View | ($4,219,088) |
| Amortization | View | $75,075 |
| Depreciation and Amortization | View | $164,374 |
| Asset Impairment Charges | View | $0 |
| Adjustment for Equity Based Compensation Expense | View | $44,266 |
| Adjustment Derivatives | View | $577,000 |
| Other Adjustments to Common Stockholders' Net Income - Increase/(Decrease) | View | $0 |
| Change in Interest Receivable | View | ($9,119) |
| Increase/(Decrease) in Deposits Outstanding | View | $77,508 |
| Change Prepaid Expenses Other Current Assets | View | ($60,519) |
| Increase/(Decrease) in Deferred Charges | View | $118,648 |
| Increase/(Decrease) in Accounts Payable and Accrued Expenses | View | ($3,827) |
| Increase/(Decrease) in Unearned Premiums | View | $2,933 |
| Net Cash Flows Provided By/(Used In) Operating Activities | View | ($3,485,785) |
| Purchase of Property, Plant and Equipment | View | $854,088 |
| Purchase of Marketable Securities | View | $5,193,165 |
| Proceeds Sale Marketable Securities | View | $8,656,266 |
| Increase Decrease Restricted Funds | View | $0 |
| Net Cash Flows Provided By/(Used In) Investing Activities | View | $2,609,013 |
| Proceeds from Related Party Debt | View | $0 |
| Other Proceeds from Issuance of Long Term Debt | View | $0 |
| Repayments of Long-Term Debt and Capital Securities | View | $0 |
| Proceeds from Issuance of Common Stock | View | $16,650 |
| Proceeds from Issuance of Convertible Preferred Stock | View | $0 |
| Net Cash Flows Provided By/(Used In) Financing Activities | View | $16,650 |
| Increase/(Decrease) in Cash and Cash Equivalents | View | ($860,122) |
| Cash and cash equivalents at the beginning of the year | View | $2,112,692 |
| Total Cash and cash equivalents at the end of the year | View | $1,252,570 |
| Cash Interest Expense | View | $0 |
| Stock Issued | View | $0 |
| Supplemental Other Net | View | $0 |
| Financial Notes: | |
| * | Amedica Corporation fiscal year end: 12/31 |
Export All Amedica Corporation Financials To Excel
$99 Single Company AccessInstant Full Site-Wide AccessAmedica Corporation Revenue from Grants ($): |
Amedica Corporation Selling and Marketing Expenses ($): |
Amedica Corporation General and Administrative Expenses ($ MM): |
Amedica Corporation Research and Development Expense (Excluding In - Process) ($ MM): |
Amedica Corporation Total Operating Expenses excluding costs ($ MM): |
Amedica Corporation Operating Income/(Loss) ($ MM): |
Amedica Corporation Interest Expense ($): |
Amedica Corporation Interest Income ($): |
Amedica Corporation Other Non-operating Gains/(Losses) ($): |
Amedica Corporation Non-operating Income/(Expense) ($): |
Amedica Corporation Net Income (Loss) ($ MM): |
Amedica Corporation Cash and Cash Equivalents ($ MM): |
Amedica Corporation Current Marketable Securities ($ MM): |
Amedica Corporation Accrued Interest ($): |
Amedica Corporation Prepaid Expenses ($): |
Amedica Corporation Current Assets ($ MM): |
Amedica Corporation Net Property, Plant and Equipment ($ MM): |
Amedica Corporation Deferred Financing Costs ($ MM): |
Amedica Corporation Restricted Cash ($): |
Amedica Corporation Deposits Assets Noncurrent ($): |
Amedica Corporation Assets ($ MM): |
Amedica Corporation Accounts Payable ($): |
Amedica Corporation Accrued Expenses ($): |
Amedica Corporation Current Deferred/(Unearned) Revenue ($): |
Amedica Corporation Current Other Deferred Liability Charges ($): |
Amedica Corporation Current Portion of Long-Term Debt ($): |
Amedica Corporation Current Liabilities ($ MM): |
Amedica Corporation Long-Term Debt ($ MM): |
Amedica Corporation Derivative Liabilities - Long-Term ($ MM): |
Amedica Corporation Deferred/(Unearned) Revenue - Long-Term ($): |
Amedica Corporation Other Deferred Long Term Liability Charges ($): |
Amedica Corporation Convertible Preferred Stock Obligations ($ MM): |
Amedica Corporation Common Stock - Value (Excluding Additional Paid in Capital) ($): |
Amedica Corporation Additional Paid in Capital ($): |
Amedica Corporation Retained Earnings ($ MM): |
Amedica Corporation Other Accumulated Comprehensive Income, Net of Tax Effect ($): |
Amedica Corporation Stockholders' Equity ($ MM): |
Amedica Corporation Liabilities and Stockholders' Equity ($ MM): |
Amedica Corporation Operating Activities Beginning Net Income ($ MM): |
Amedica Corporation Amortization ($): |
Amedica Corporation Depreciation and Amortization ($): |
Amedica Corporation Adjustment for Equity Based Compensation Expense ($): |
Amedica Corporation Adjustment Derivatives ($): |
Amedica Corporation Change in Interest Receivable ($): |
Amedica Corporation Increase/(Decrease) in Deposits Outstanding ($): |
Amedica Corporation Change Prepaid Expenses Other Current Assets ($): |
Amedica Corporation Increase/(Decrease) in Deferred Charges ($ MM): |
Amedica Corporation Increase/(Decrease) in Accounts Payable and Accrued Expenses ($): |
Amedica Corporation Increase/(Decrease) in Unearned Premiums ($): |
Amedica Corporation Net Cash Flows Provided By/(Used In) Operating Activities ($ MM): |
Amedica Corporation Purchase of Property, Plant and Equipment ($ MM): |
Amedica Corporation Purchase of Marketable Securities ($ MM): |
Amedica Corporation Proceeds Sale Marketable Securities ($ MM): |
Amedica Corporation Increase Decrease Restricted Funds ($): |
Amedica Corporation Net Cash Flows Provided By/(Used In) Investing Activities ($ MM): |
Amedica Corporation Other Proceeds from Issuance of Long Term Debt ($ MM): |
Amedica Corporation Proceeds from Issuance of Common Stock ($): |
Amedica Corporation Proceeds from Issuance of Convertible Preferred Stock ($ MM): |
Amedica Corporation Net Cash Flows Provided By/(Used In) Financing Activities ($ MM): |
Amedica Corporation Increase/(Decrease) in Cash and Cash Equivalents ($): |
Amedica Corporation Cash and cash equivalents at the beginning of the year ($ MM): |
Amedica Corporation Total Cash and cash equivalents at the end of the year ($ MM): |
Amedica Corporation Cash Interest Expense ($): |
Amedica Corporation Supplemental Other Net ($): |
Export Financials to Excel
$99 Single Company AccessInstant Full Site-Wide Access| Date | Investor | Round | Investor Type | |
| Feb. 2004 | Undisclosed Investors | A | ||
| Details | Total Round A $8,400,000 | |||
| Dec. 2004 | Undisclosed Investors | B | ||
| Details | Total Round B $6,000,000 | |||
| Mar. 2006 | View | C | ||
| Details | Total Round C View | |||
| May. 2007 | View | D | ||
| Details | Total Round D View | |||
| Feb. 2010 | View | E | ||
| Details | Total Round E View | |||
| Mar. 2011 | View | Debt Funding | ||
| Details | Total Round Debt Funding1 View | |||
| Dec. 2012 | View | F | ||
| Details | Total Round F View | |||
| Jan. 2013 | View | Debt Funding | Lender | |
| Details | Total Round Debt Funding View | |||
| Total of Funding Shown Above View | ||||
| 1 | Out...Read More → |
Full-length notes are available with Single Report Access or PrivCo Premium Subscription. |
Missing a deal? Tell us about it! tips@privco.com
|
Get Full Access To This Report
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
PrivCo is the authority for financial & business data on major private companies, including:
| Private Companies | 209,271 |
| Private Investors | 12,046 |
| Private M&A Deals | 43,225 |
| VC/Funding Rounds | 36,158 |
| Total Data Points | 95,786,176 |
You are viewing a free limited preview of Amedica Corporation
PrivCo is the premier source for business and financial data on major, non-publicly traded corporations, including family owned, private equity owned, venture backed, and international unlisted companies. Click here to learn more.
PDF VERSION: Download Company Report in PDF Format
Full Online Report
